2-Methyl-6-prop-1-enylpiperidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2-Methyl-6-prop-1-enylpiperidine
• 化学式: C₉H₁₇N
• 分子量: 139.241
• InChiKey: CXQRNYIKPJXYLU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-Methyl-octa-5,6-dienylamine 在 [Me2Si(η5-Me4C5)(t-BuN)]U(NMe2)2 作用下， 以 氘代苯 为溶剂， 生成 2-Methyl-6-prop-1-enylpiperidine
  参考文献：
  名称：

  Constrained Geometry Organoactinides as Versatile Catalysts for the Intramolecular Hydroamination/Cyclization of Primary and Secondary Amines Having Diverse Tethered C−C Unsaturation

  摘要：

  A series of "constrained geometry" organoactinide complexes, (CGC)An(NMe)(2) (CGC = Me2Si(eta(5)-Me4C5)((BuN)-Bu-t); An = Th, 1; U, 2), has been prepared via efficient in situ, two-step protodeamination routes in good yields and high purity. Both 1 and 2 are quantitatively converted to the neutrally charged, solvent-free dichlorides (1-Cl-2, 2-Cl-2) and slightly more soluble diiodides (1-I-2, 2-I-2) with excess Me3Si-X (X = Cl, I) in non-coordinating solvents. The new complexes were characterized by NMR spectroscopy, elemental analysis, and (for 1 and 2) single-crystal X-ray diffraction, revealing substantially increased metal coordinative unsaturation vs the corresponding Me2SiCp ''(2)AnR(2) (Cp '' = eta(5)-Me4C5; An = Th, R = CH2(SiMe3), 3; An = U, R = CH2Ph, 4) and Cp'(2)AnR(2) (Cp' = eta(5)-Me5C5 ; An = Th, R = CH2(SiMe3), 5; An = U, R = CH2(SiMe3), 6) complexes. Complexes 1-6 exhibit broad applicability for the intramolecular hydroamination of diverse C-C unsaturations, including terminal and internal aminoalkenes (primary and secondary amines), aminoalkynes (primary and secondary amines), aminoallenes, and aminodienes. Large turnover frequencies (N-t up to 3000 h(-1)) and high regioselectivities (>= 95%) are observed throughout, along with moderate to high diastereoselectivities (up to 90% trans ring closures). With several noteworthy exceptions, reactivity trends track relative 5f ionic radii and ancillary ligand coordinative unsaturation. Reactivity patterns and activation parameters are consistent with a reaction pathway proceeding via turnover-limiting CC/CC insertion into the An-N sigma-bond.

  DOI：

  10.1021/ja0665444

文献信息

• Solenopsin a, b and analogs and as novel angiogenesis inhibitors
  申请人：Bowen Phillip J.

  公开号：US20050038071A1

  公开（公告）日：2005-02-17

  The present invention relates to solenopsin A and its analogs for use as angiogenesis inhibitors. The present compounds unexpectedly exhibit good activity as angiogenesis inhibitors, which find use as antitumor/anticancer agents as well as to treat a number of conditions or disease states in which angiogenesis is a factor.

  本发明涉及用于作为血管生成抑制剂的溶蚁毒素A及其类似物。本化合物意外地表现出良好的作为血管生成抑制剂的活性，可用作抗肿瘤/抗癌剂以及治疗许多与血管生成有关的疾病状态。
• US6369078B1
  申请人：——

  公开号：US6369078B1

  公开（公告）日：2002-04-09
• US8168657B2
  申请人：——

  公开号：US8168657B2

  公开（公告）日：2012-05-01
• [EN] SOLENOPSIN A, B AND ANALOGS AS NOVEL ANGIOGENESIS INHIBITORS<br/>[FR] SOLENOPSINE A, B ET ANALOGUES UTILISES COMME NOUVEAUX INHIBITEURS DE L'ANGIOGENESE
  申请人：UNIV GEORGIA RES FOUND

  公开号：WO2003061598A2

  公开（公告）日：2003-07-31

  The present invention relates to solenopsin A and its analogs for use as angiogenesis inhibitors. The present compounds unexpectedly exhibit good activity as angiogenesis inhibitors, which find use as antitumor/anticancer agents as well as to treat a number of conditions or disease states in which angiogenesis is a factor.